Ambulatory Payment Classes: Obstacle or Opportunity for Health Care Systems?

2000 ◽  
Vol 35 (2) ◽  
pp. 114-119
Author(s):  
C. Nick Wilson
Keyword(s):  
Health Care ◽  
Managed Care ◽  
Health Services ◽  
Health Care Systems ◽  
Quality Health Care ◽  
Managed Health Care ◽  
Quality Health ◽  
Care Systems ◽  
The Many ◽  
The Impact

Managed health care has changed the way health services are provided and paid for. It is still evolving. Many pharmacists have already felt the impact of these changes. This continuing feature illuminates the many facets of managed care with special emphasis placed on how these changes may affect pharmacists working in health systems. The expertise provided by pharmacists will be needed to fulfill the potential of affordable, comprehensive, and quality health care as promised by managed care. Pharmacists must understand what is happening, why it is happening, and what is likely to happen in the future. To be an active and effective player, you must understand what is happening on the field.

Consumer-Driven Health Care

2000 ◽  
Vol 35 (5) ◽  
pp. 477-478
Author(s):  
F. Randy Vogenberg
Keyword(s):  
Health Care ◽  
Managed Care ◽  
Health Services ◽  
Health Systems ◽  
Quality Health Care ◽  
Managed Health Care ◽  
The Future ◽  
Quality Health ◽  
The Many ◽  
The Impact

Managed health care has changed the way health services are provided and paid for. It is still evolving. Many pharmacists have already felt the impact of these changes. This continuing feature illuminates the many facets of managed care with special emphasis placed on how these changes may affect pharmacists working in health systems. The expertise provided by pharmacists will be needed to fulfill the potential of affordable, comprehensive, and quality health care as promised by managed care. Pharmacists must understand what is happening, why it is happening, and what is likely to happen in the future. To be an active and effective player, you must understand what is happening on the field.

Reining in the Pharmacy Budget

2000 ◽  
Vol 35 (4) ◽  
pp. 354-356
Author(s):  
F. Randy Vogenberg
Keyword(s):  
Health Care ◽  
Managed Care ◽  
Health Services ◽  
Health Systems ◽  
Quality Health Care ◽  
Managed Health Care ◽  
The Future ◽  
Quality Health ◽  
The Many ◽  
The Impact

Managed health care has changed the way health services are provided and paid for. It is still evolving. Many pharmacists have already felt the impact of these changes. This continuing feature illuminates the many facets of managed care with special emphasis placed on how these changes may affect pharmacists working in health systems. The expertise provided by pharmacists will be needed to fulfill the potential of affordable, comprehensive, and quality health care as promised by managed care. Pharmacists must understand what is happening, why it is happening, and what is likely to happen in the future. To be an active and effective player, you must understand what is happening on the field.

Talking about and Using Pharmacoeconomics Properly

2001 ◽  
Vol 36 (7) ◽  
pp. 717-722
Author(s):  
F. Randy Vogenberg
Keyword(s):  
Health Care ◽  
Managed Care ◽  
Health Services ◽  
Health Systems ◽  
Quality Health Care ◽  
Managed Health Care ◽  
The Future ◽  
Quality Health ◽  
The Many ◽  
The Impact

Managed health care has changed the way health services are provided and paid for. It is still evolving. Many pharmacists have already felt the impact of these changes. This continuing feature illuminates the many facets of managed care with special emphasis placed on how these changes may affect pharmacists working in health systems. The expertise provided by pharmacists will be needed to fulfill the potential of affordable, comprehensive, and quality health care as promised by managed care. Pharmacists must understand what is happening, why it is happening, and what is likely to happen in the future. To be an active and effective player, you must understand what is happening on the field.

Institutional Pharmacoeconomics: Who Benefits?

2002 ◽  
Vol 37 (6) ◽  
pp. 668-671
Author(s):  
F. Randy Vogenberg
Keyword(s):  
Health Care ◽  
Health Care Systems ◽  
High Quality ◽  
Quality Health Care ◽  
Managed Health Care ◽  
Quality Health ◽  
Care Systems ◽  
High Quality Health Care ◽  
The Many ◽  
The Impact

Managed health care has changed the way health services are provided and paid for. Many pharmacists have already felt the impact of these changes. This continuing feature illuminates the many facets of managed care, with a special emphasis on how these changes are affecting pharmacists working in health systems. Managed health care systems are still evolving, and the expertise of pharmacists will be needed for these systems to attain their primary goal: the delivery of affordable, comprehensive, high-quality health care.

Hospice and Palliative Care in Managed Care Organizations

2001 ◽  
Vol 36 (5) ◽  
pp. 487-496
Author(s):  
F. Randy Vogenberg
Keyword(s):  
Health Care ◽  
Palliative Care ◽  
Managed Care ◽  
Quality Health Care ◽  
Managed Health Care ◽  
Quality Health ◽  
The Many ◽  
Hospice And Palliative Care ◽  
The Impact ◽  
Managed Care Organizations

Managed health care has changed the way health services are provided and paid for. It is still evolving. Many pharmacists have already felt the impact of these changes. This continuing feature illuminates the many facets of managed care with special emphasis placed on how these changes may affect pharmacists working in health systems. The expertise provided by pharmacists will be needed to fulfill the potential of affordable, comprehensive, and quality health care as promised by managed care. Pharmacists must understand what is happening, why it is happening, and what is likely to happen in the future. To be an active and effective player, you must understand what is happening on the field.

scholarly journals The Impact and Implications of The COVID-19 Pandemic on Organ Procurement Outside of an Epicenter

2021 ◽  
pp. 152692482110028
Author(s):  
Janice Jene Hudgins ◽  
Allison Jo Boyer ◽  
Kristen Danielle Orr ◽  
Clint Allen Hostetler ◽  
Jeffrey Paul Orlowski ◽  
...  
Keyword(s):  
Health Care ◽  
Initial Phase ◽  
Organ Procurement ◽  
Health Care Systems ◽  
Health Data ◽  
Organ Procurement Organization ◽  
Care Systems ◽  
The Impact ◽  
Variable Impact ◽  
Single Organ

The COVID-19 pandemic has been well-documented to have a variable impact on individual communities and health care systems. We describe the experience of a single organ procurement organization (OPO), located in an area without a large cluster of cases during the initial phase of the COVID-19 pandemic. A review of community health data describing the impact of COVID-19 nationally and in Oklahoma was conducted. Additionally, a retrospective review of available OPO data from March 2019-May 2020 was performed. While the amount of donor referrals received and organs recovered by the OPO remained stable in the initial months of the pandemic, the observed organs transplanted vs. expected organs transplanted (O:E) decreased to the lowest number in the 15-month period and organs transplanted decreased as well. Fewer organs from Oklahoma donors were accepted for transplant despite staff spending more time allocating organs.

scholarly journals Sustainability of Biosimilars in Europe: A Delphi Panel Consensus with Systematic Literature Review

2020 ◽  
Vol 13 (11) ◽  
pp. 400
Author(s):  
Arnold G. Vulto ◽  
Jackie Vanderpuye-Orgle ◽  
Martin van der Graaff ◽  
Steven R. A. Simoens ◽  
Lorenzo Dagna ◽  
...  
Keyword(s):  
Health Care ◽  
Literature Review ◽  
Systematic Literature Review ◽  
Health Care Systems ◽  
Delphi Panel ◽  
The European Union ◽  
Modified Delphi ◽  
Care Systems ◽  
Supply Risks ◽  
The Impact

Introduction: Biosimilars have the potential to enhance the sustainability of evolving health care systems. A sustainable biosimilars market requires all stakeholders to balance competition and supply chain security. However, there is significant variation in the policies for pricing, procurement, and use of biosimilars in the European Union. A modified Delphi process was conducted to achieve expert consensus on biosimilar market sustainability in Europe. Methods: The priorities of 11 stakeholders were explored in three stages: a brainstorming stage supported by a systematic literature review (SLR) and key materials identified by the participants; development and review of statements derived during brainstorming; and a facilitated roundtable discussion. Results: Participants argued that a sustainable biosimilar market must deliver tangible and transparent benefits to the health care system, while meeting the needs of all stakeholders. Key drivers of biosimilar market sustainability included: (i) competition is more effective than regulation; (ii) there should be incentives to ensure industry investment in biosimilar development and innovation; (iii) procurement processes must avoid monopolies and minimize market disruption; and (iv) principles for procurement should be defined by all stakeholders. However, findings from the SLR were limited, with significant gaps on the impact of different tender models on supply risks, savings, and sustainability. Conclusions: A sustainable biosimilar market means that all stakeholders benefit from appropriate and reliable access to biological therapies. Failure to care for biosimilar market sustainability may impoverish biosimilar development and offerings, eventually leading to increased cost for health care systems and patients, with fewer resources for innovation.

scholarly journals The impact of chronic disease and disability on the elderly

1999 ◽  
Vol 55 (3) ◽  
pp. 9-14
Author(s):  
C. J. Eales
Keyword(s):  
Health Care ◽  
Chronic Disease ◽  
Chronic Diseases ◽  
Health Care Systems ◽  
The Elderly ◽  
Therapeutic Interventions ◽  
Elderly Persons ◽  
Care Systems ◽  
And Function ◽  
The Impact

Health care systems for elderly people should aim to delay the onset of illness, reducing the final period of infirmity and illness to the shortest possible time. The most effective way to achieve this is by health education and preventative medicine to maintain mobility and function. Changes in life style even in late life may result in improved health, effectively decreasing the incidence of chronic diseases associated with advancing age. This paper presents the problems experienced by elderly persons with chronic diseases and disabilities with indications for meaningful therapeutic interventions.

Sign in / Sign up

Export Citation Format

Share Document